Testimony of
Donald R. Vereen, JR., M.D., M.P.H.
Deputy Director, Office of National Drug Control Policy
Before the
US Senate Caucus on International Narcotics Control
"America at Risk: The Ecstasy Threat"
Wednesday, March 21, 2001
Entire Document in Adobe Acrobat (48K)
- Introduction
- MDMA is not a benign substance
- The prevalence of MDMA use is increasing, particularly among youth.
- The public-health consequences of MDMA use are also increasing.
- ONDCP's responses to the MDMA problem
- NIDA'S Initiative to Combat Club Drugs
- Conclusion
- Figure 1
Last Updated: March 4, 2002
